United Europeans for development of pharmacogenomics in multiple sclerosis network

Author： Vandenbroeck Koen   Comabella Manuel   Tolosa Eva   Goertsches Robert   Brassat David   Hintzen Rogier   Infante-Duarte Carmen   Favorov Alexander   Escorza Sergio   Palacios Ricardo   Oksenberg Jorge R   Villoslada Pablo  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.5, 2009-05, pp. : 885-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

IFN-&bgr; pharmacogenomics in multiple sclerosis

By Vandenbroeck Koen   Urcelay Elena   Comabella Manuel  

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1137-1148

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Multiple Sclerosis: Current Status and Potential Applications

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 4, 2010-12 ,pp. : 273-279

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of IFN-&bgr;β in multiple sclerosis: towards a personalized medicine approach

By Vosslamber Saskia   van Baarsen Lisa GM   Verweij Cornelis L  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 97-108

Future Medicine

Access to resources Recommend Favorite

Drugs in Clinical Development for Multiple Sclerosis: Summary and Table

By  

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite

Development of interferon-β as a therapy for multiple sclerosis

By Markowitz Clyde  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 363-374

Informa Healthcare

Access to resources Recommend Favorite